SRXH SRX Global Inc.
$1.08▲ +3.85%
ConsumerStaples
Other
After hours
$1.05▼ -2.78%
Oct 27, 5:20 PM ET
Volume 277.8K
Avg Volume (10D) 427.0K
Key Metrics & Fundamentals
Market Cap
$21.80M
P/E Ratio
0.0
Div Yield
0.00%
52W Range
0.96 - 42.60
% vs 50 MA
-29.62%
% vs 200 MA
-79.77%
RSI-14
27.7
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.52
Free Cash Flow
-$956,000
Gross Rev
$3.39M
Gross Profit
$904,000
EBITDA
-$4.62M
COGS
$2.49M
Operating Exp
$4.11M
Operating Income
-$3.20M
EBIT
-$3.20M
Pretax Income
-$4.14M
Net Income
-$4.14M
EPS (Diluted)
-21.60
Price & Volume History
Loading chart…
Recent News
SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies
GlobeNewswire · Oct 26, 2026 9:05 AM ET
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
GlobeNewswire · Oct 8, 2026 8:35 AM ET
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
GlobeNewswire · Oct 7, 2026 3:00 PM ET
SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
GlobeNewswire · Oct 6, 2026 4:20 PM ET
SRX Global Makes Investment in Onconetix
MT Newswires · Sep 24, 2026 1:14 PM ET
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
GlobeNewswire · Sep 24, 2026 12:30 PM ET
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
GlobeNewswire · Sep 23, 2026 4:05 PM ET
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
GlobeNewswire · Sep 3, 2026 8:15 AM ET
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
GlobeNewswire · Aug 31, 2026 7:30 AM ET
SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ...
GuruFocus.com · Aug 14, 2026 1:02 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SRXH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.